Categories AlphaGraphs, Earnings, Health Care
AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase in revenues. The numbers exceeded estimates.
The company reported worldwide net revenues of $14.46 billion for the June quarter, up 4.3% from the corresponding period of 2023 and above the market’s projection. All operating segments, except the Eye Care division, registered growth.
Net income, adjusted for special items, declined to $2.65 per share in Q2 from $2.91 per share in the year-ago quarter, but topped expectations. On a reported basis, second-quarter profit was $1.37 billion or $0.77 per share, compared to $2.02 billion or $1.14 per share last year.
Prior Performance
Most Popular
Key highlights from Hewlett Packard Enterprise’s (HPE) Q1 2025 earnings results
Hewlett Packard Enterprise (NYSE: HPE) reported its first quarter 2025 earnings results today. Revenue was $7.9 billion, up 16% year-over-year and 17% in constant currency. Net earnings attributable to common
AVGO Infographic: Broadcom Q1 2025 revenue and earnings beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenue and adjusted earnings for the first quarter of 2025. The numbers also surpassed Wall Street's expectations. Earnings, excluding special items, increased
Macy’s (M) Q4 2024 Earnings: Key financials and quarterly highlights
Macy’s Inc. (NYSE: M) reported its fourth quarter 2024 earnings results today. Net sales decreased 4.3% year-over-year to $7.8 billion. Comparable sales were down 1.1% on an owned basis and
